Meir Wetzler - Concepedia

Author

Meir Wetzler

Roswell Park Comprehensive Cancer Center ORCID

Also Known As

Donald Trump, M A Wetzler, M Wetzler, M. WETZLER, M. Wetzler, MEIR WETZLER, Meir Wetzler, Wetzler M, Wetzler Meir

384

Publications

15.5K

Citations

H-Index

158

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center University at Buffalo, State University of New York The Ohio State University University of Chicago

About

Meir Wetzler is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	66	4K
2	Health Sciences	17	21	840
3	Natural Sciences	6	6	290
4	Nursing	2	2	51
5	Engineering	1	1	74

Meir Wetzler

144

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola, Blood	2014	960
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS Jan Krönke, Emma C. Fink, Paul W. Hollenbach, Nature MedicineCell DeathPharmacologyCell BiologyCell Signaling	2015	816
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Guido Marcucci, Kati Maharry, Yue-Zhong Wu, Journal of Clinical Oncology	2010	757
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi, Cancer Cell Hematological MalignancyPh Chromosome-positive LeukemiaGeneticsMolecular GeneticsCancer Genetics	2014	363
Favorable Prognostic Impact of <i>NPM1</i> Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study Heiko Becker, Guido Marcucci, Kati Maharry, Journal of Clinical Oncology	2009	339
<i>TET2</i> Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Klaus H. Metzeler, Kati Maharry, Michael D. Radmacher, Journal of Clinical Oncology	2011	319
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, PubMed	1999	313
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category Klaus H. Metzeler, Heiko Becker, Kati Maharry, Blood	2011	274
<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures Jason H. Mendler, Kati Maharry, Michael D. Radmacher, Journal of Clinical Oncology	2012	265
Age-Related Prognostic Impact of Different Types of <i>DNMT3A</i> Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia Guido Marcucci, Klaus H. Metzeler, Sebastian Schwind, Journal of Clinical Oncology	2012	255

Page 1